Calcipotriol abrogates TGF-β1/pSmad3-mediated collagen 1 synthesis in pancreatic stellate cells by downregulating

Meifang Zheng1, Hongyan Li1, Li Sun1

  • 1Department of Hepatic biliary Pancreatic Medicine, First Hospital of Jilin University, Changchun, China.

Insights

RUNX1 activates collagen synthesis in pancreatic stellate cells via the TGF-β1/pSmad3 pathway. Calcipotriol inhibits this process by downregulating RUNX1, suggesting RUNX1 as a potential antifibrotic target for pancreatitis.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Gastroenterology

Background:

  • RUNX1, in complex with CBFβ, regulates key cellular functions.
  • Transforming growth factor-beta 1 (TGF-β1) is implicated in fibrotic processes.
  • Pancreatic stellate cells (PSCs) play a central role in pancreatic fibrosis.

Purpose of the Study:

  • To elucidate RUNX1's role in TGF-β1-induced collagen type 1 (COL1) synthesis in PSCs.
  • To investigate the mechanism by which calcipotriol (Cal) antagonizes COL1 synthesis.
  • To identify potential antifibrotic therapeutic targets for chronic pancreatitis.

Main Methods:

  • Quantitative real-time PCR (RT-qPCR) and Western blotting for RUNX1 and COL1A1/1A2.
  • Luciferase reporter assays for promoter activity.
  • Co-immunoprecipitation and immunoblotting for protein interactions (pSmad3/RUNX1, CBFβ/RUNX1).
  • Gene knockdown and upregulation experiments for Smad3 and RUNX1.

Main Results:

  • TGF-β1/pSmad3 signaling pathway regulates RUNX1 production in PSCs.
  • RUNX1 and CBFβ form a coactivator complex (pSmad3/RUNX1/CBFβ) that drives COL1A1/1A2 transcription.
  • Calcipotriol inhibits COL1A1/1A2 transcript levels by reducing RUNX1 and disrupting the pSmad3/RUNX1/CBFβ complex formation.

Conclusions:

  • RUNX1 is a key regulator of TGF-β1-induced collagen synthesis in pancreatic stellate cells.
  • Calcipotriol's antifibrotic effect is mediated through the downregulation of RUNX1 and its coactivator complex.
  • RUNX1 represents a promising antifibrotic therapeutic target for chronic pancreatitis.

Related Concept Videos

TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.3K
T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
963
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
8.7K